Schedule 13D ownership disclosure
Accelerate Diagnostics, Inc
Common Stock, par value $0.001 per share · CUSIP: 00430H102
Event date: 2025-02-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Indaba Capital Management, L.P.Reported CIK 0001524362
Shares: 2,751,762.00 · Class: 9.9%
- IC GP, LLCReported CIK 0001596505
Shares: 2,751,762.00 · Class: 9.9%
- Derek C. SchrierReported CIK 0001250078
Shares: 2,751,762.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-010077
- Form type
- SCHEDULE 13D/A
- Filer
- Accelerate Diagnostics, Inc
- CIK
- CIK 727207
- Filed
- Feb 06, 2025
- Reporting period
- Feb 04, 2025
- Description
- Schedule 13D beneficial ownership